Back to PathoKing

SLE module

Systemic Lupus Erythematosus

Understand systemic lupus erythematosus as loss of nuclear self-tolerance with autoantibody and immune-complex injury affecting skin, joints, blood, kidneys, serosa, vessels and the nervous system.

advanced45 min

Clinically reviewed by Mark · NMC-registered nurse

Aetiology

What shapes SLE susceptibility and flares?

SLE emerges from immune susceptibility plus triggers that increase nuclear antigen exposure or immune activation.

Polygenic immune susceptibility

Typical setting: Family clustering and variants in HLA, complement, interferon and lymphocyte pathways.

Multiple variants lower the threshold for loss of tolerance; rare early complement deficiencies strongly impair immune-complex clearance.

Hormonal and sex-linked influences

Typical setting: SLE is much more common in women, particularly during reproductive years.

Oestrogenic and X-linked immune effects alter B-cell survival and innate responses, but sex alone neither causes nor excludes disease.

Ultraviolet exposure

Typical setting: Sunlight preceding photosensitive rash or flare.

UV injury increases keratinocyte apoptosis and surface expression of nuclear antigens, feeding local and systemic autoimmunity.

Infection and immune activation

Typical setting: Viral or bacterial illness around symptom worsening.

Innate and adaptive activation can trigger flare, while immunosuppression makes infection a dangerous mimic that must be excluded.

Drug-induced lupus-like disease

Typical setting: Selected medicines produce lupus manifestations and characteristic antibody patterns.

Epigenetic or immune effects can break tolerance; the phenotype often differs from idiopathic SLE and may improve after withdrawal.

Smoking

Typical setting: Ongoing tobacco exposure.

Oxidative tissue injury and immune effects can worsen cutaneous disease, cardiovascular risk and response to some therapies.

Mechanism chain

Mechanism chain

Impaired nuclear-debris clearance drives autoantibodies, immune complexes, complement activation and organ-specific injury.

1

Nuclear self-antigens persist

Increased cell death or impaired clearance exposes DNA, RNA and nucleoproteins to antigen-presenting cells.

2

Tolerance to nuclear material is lost

Autoreactive T and B cells survive checkpoints and respond to nuclear antigens, supported by interferon and B-cell survival signals.

Checking account access...